Opinion: Direct-to-consumer advertising of prescription medicines: a counter argument

Abstract

Direct-to-consumer advertising of prescription-only medicines is currently only permitted in the USA and New Zealand. Barbara Mintzes and Dee Mangin provide their case against direct-to-consumer advertising of prescription medicines, arguing that its wider introduction would lead to a 'Pharma-knows-best' culture.

Authors

Mintzes B; Mangin D

Journal

Future Medicinal Chemistry, Vol. 1, No. 9, pp. 1555–1560

Publisher

Taylor & Francis

Publication Date

December 2009

DOI

10.4155/fmc.09.136

ISSN

1756-8919

Associated Experts

Derelie A Mangin

Professor (Part-Time), Faculty of Health Sciences

Visit profile

Labels